A recent metabolomics study has identified biomarkers from particular foods, which could help in establishing the connection between diet and Type 2 Diabetes, quantitatively.
Study identified blood-based biomarkers, which could be used alongside traditional methods to improve the diagnosis of sepsis.
Researchers evaluate the use of inflammatory molecules as potential biomarkers for amyotrophic lateral sclerosis
Levels of inflammatory molecules could be utilised as diagnostic markers for amyotrophic lateral sclerosis.
A DNA methylation biomarker (POU4F3) and quantitative assay may provide a two-pronged approach to improve the preclinical identification and diagnosis of cervical cancers.
Live event: Tuesday 3 October 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
This webinar will explore this continuum of fit-for-purpose validation, from the validation of early exploratory biomarker analysis, to the amalgamation of FDA GLP and CLIA GLP biomarker validation guidelines in the bioanalytical lab.
A perspective on the challenges and issues in developing biomarkers for human allergic risk assessments
In this commentary the authors explore developing biomarkers for allergic risk assessments and the challenges and issues involved.
Novel preoperative biomarkers could be strong prognostic indicators in pancreatic ductal adenocarcinomas
Could two novel biomarkers change the standard in care and treatment of pancreatic ductal adenocarcinomas? Recent research suggests a change in preoperative prognoses and a step forward in personalized medicine.
Researchers have identified a new biomarker for a group of rare metabolic disorders, mucopolysaccharidoses, which could facilitate better diagnosis.
Researchers have identified new biomarkers that could aid stage-specific diagnosis of Alzheimer’s, leading to advancements in treatment.
Findings, published in The Lancet, Diabetes & Endocrinology, record the results from a large collaborative…